ZTS Zoetis
- Official Name: ZOETIS INC.
- Headquarters: 10 Sylvan Way, PARSIPPANY, NJ, 07054 US
- CEO: Kristin C. Peck
- Website: zoetis.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1 | Lost by 1.927 | (1.453) - 0.474 | ||
| 2025-07-15 | 1R | Won by 0.079 | (1.139) - (1.218) | ||
| 2025-07-16 | 1R | Lost by 0.240 | (0.079) - 0.161 | ||
| 2025-07-22 | 2 | Won by 3.178 | 1.019 - (2.159) | ||
| 2025-07-29 | 3 | Won by 1.677 | 0.185 - (1.492) | ||
| 2025-07-29 | 2R | Won by 1.432 | 0.424 - (1.008) | ||
| 2025-08-05 | 4 | Lost by 0.313 | (1.264) - (0.951) | ||
| 2025-08-07 | 1R | Won by 1.057 | 1.216 - 0.159 | ||
| 2025-08-12 | 5 | Won by 2.717 | 4.280 - 1.563 | ||
| 2025-08-12 | 3R | Lost by 1.468 | 0.450 - 1.918 | ||
| 2025-08-19 | 6 | Won by 2.014 | 3.150 - 1.136 | ||
| 2025-08-21 | 2R | Won by 0.117 | (0.795) - (0.912) | ||
| 2025-08-26 | 7 | Lost by 3.755 | (0.528) - 3.227 | ||
| 2025-09-02 | 8 | Won by 1.971 | (1.350) - (3.321) | ||
| 2025-09-04 | 3R | Won by 0.028 | 0.515 - 0.487 | ||
| 2025-09-09 | 9 | Won by 4.188 | (2.170) - (6.358) | ||
| 2025-09-11 | 4R | Lost by 0.997 | 0.860 - 1.857 | ||
| 2025-09-16 | 10 | Won by 0.604 | (1.772) - (2.376) | ||
| 2025-09-23 | 11 | Lost by 5.878 | (3.358) - 2.520 | ||
| 2025-09-30 | 12 | Won by 0.624 | 2.427 - 1.803 | ||
| 2025-10-07 | 13 | Lost by 2.884 | (2.160) - 0.724 | ||
| 2025-10-14 | 14 | Won by 2.599 | 0.410 - (2.189) | ||
| 2025-10-21 | 15 | Won by 5.112 | 1.801 - (3.311) |
Latest News
Goldman Sachs Initiates Coverage On Zoetis with Neutral Rating, Announces Price Target of $74
Goldman Sachs analyst Matt Dellatorre initiates coverage on Zoetis (NYSE:ZTS) with a Neutral rating and announces Price Target of $74.

Zoetis (ZTS) Hit by Guidance Cuts, Met with Market Shrug
Middle Coast Investing, an investment advisor firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Market breadt...

3 Reasons ZTS is Risky and 1 Stock to Buy Instead
Zoetis has gotten torched over the last six months - since April 2026, its stock price has dropped 37.6% to $75.34 per share. This was partly due to i...
Zoetis (NYSE:ZTS): A Quality Investing Case Study in Animal Health
Zoetis quality investing analysis: high ROIC, strong cash flow, low debt, reasonable valuation, but revenue growth lags Caviar Cruise screen criteria.

Zoetis (ZTS) Board Update And Dividend Keep Undervalued Narrative In Focus
Board appointment and dividend set the stage for Zoetis Zoetis (ZTS) has given investors fresh governance and income headlines in October, with Iris K...

Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are ...

Zoetis Appoints Iris Knobloch to its Board of Directors
PARSIPPANY, N.J., October 13, 2026--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Iris Knobloch to its Board of Directors, effective as of...

10 Dividend Growth Stocks: October 2026
An equally weighted portfolio of the top 10 stocks yields 2.8% but would have underperformed SPY over the past 5 years. Check out dividend growth stoc...